Control group:Valsartan 80mg/d

2 trials

Sponsors

Zhongshan Hospital, Fudan University, West China Hospital of Sichuan University

Conditions

Hypertensive nephropathyimmunoglobulin A nephropathy

Phase 4

Prospective trial of leflunomide in the treatment of immunoglobulin A nephropathy

Active, not recruitingChiCTR-IPR-14005368

West China Hospital of Sichuan Universityimmunoglobulin A nephropathy

Start: 2014-11-01Updated: 2017-04-18

Unknown Phase

Study on the effect of azilsartan on the early index of renal injury

Active, not recruitingChiCTR2300073557

Zhongshan Hospital, Fudan UniversityHypertensive nephropathy

Start: 2023-08-01Updated: 2023-07-16